TY - JOUR
T1 - Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
AU - BELNEU Consortium
AU - EU EOD Consortium
AU - Van Der Zee, Julie
AU - Van Langenhove, Tim
AU - Kovacs, Gabor G.
AU - Dillen, Lubina
AU - Deschamps, William
AU - Engelborghs, Sebastiaan
AU - Matěj, Radoslav
AU - Vandenbulcke, Mathieu
AU - Sieben, Anne
AU - Dermaut, Bart
AU - Smets, Katrien
AU - Van Damme, Philip
AU - Merlin, Céline
AU - Laureys, Annelies
AU - Van Den Broeck, Marleen
AU - Mattheijssens, Maria
AU - Peeters, Karin
AU - Benussi, Luisa
AU - Binetti, Giuliano
AU - Ghidoni, Roberta
AU - Borroni, Barbara
AU - Padovani, Alessandro
AU - Archetti, Silvana
AU - Pastor, Pau
AU - Razquin, Cristina
AU - Ortega-Cubero, Sara
AU - Hernández, Isabel
AU - Boada, Mercè
AU - Ruiz, Agustín
AU - De Mendonça, Alexandre
AU - Miltenberger-Miltényi, Gabriel
AU - Do Couto, Frederico Simões
AU - Sorbi, Sandro
AU - Nacmias, Benedetta
AU - Bagnoli, Silvia
AU - Graff, Caroline
AU - Chiang, Huei Hsin
AU - Thonberg, Håkan
AU - Perneczky, Robert
AU - Diehl-Schmid, Janine
AU - Alexopoulos, Panagiotis
AU - Frisoni, Giovanni B.
AU - Bonvicini, Christian
AU - Synofzik, Matthis
AU - Maetzler, Walter
AU - Vom Hagen, Jennifer Müller
AU - Schöls, Ludger
AU - Haack, Tobias B.
AU - Strom, Tim M.
AU - Prokisch, Holger
N1 - Funding Information:
genetic Service Facility for their support of the genetic analyses and to the different neurological centers for their contribution to the diagnosis and sampling of patients. The data generation for this paper was in part funded by the Metlife Award for Medical research to C.V.B., USA; the Belgian Science Policy Office (BelSPO) Interuniversity Attraction Poles program, the Flemish government support to the european Initiative on Centers of excellence in Neurodegeneration (CoeN), the Flemish government initiated Methusalem excellence program, the Alzheimer research Foundation (SAO/FrA), the Medical Foundation Queen elisabeth, the research Foundation Flanders (FWO), the Agency for Innovation by Science and Technology Flanders (IWT) and the University of Antwerp research Fund, Belgium. The FWO provided a postdoctoral fellowship to J.v.d.Z. and a clinical investigatorship to P.V.D. The Brescia IRCCS Fatebenefratelli site was funded by the ricerca Corrente, Italian Ministry of Health. r.g. was funded by Fondazione CArIPlO, grant Number 2009-2633. The Barcelona ACE site thank the patients and controls who participated in this project. We are indebted to Trinitat Port-Carbó and her family who are supporting Fundació ACe research programs. The Lisbon site acknowledges a grant by grunenthal. The Florence site acknowledges Prin 2010-prot. 2010PWNJXK; Cassa di rispario di Firenze e Cassa di risparmio di Pistoia e Pescia. The Stockholm site was financially supported by the Programme in Neuroscience at Karolin-ska Institutet (StratNeuro); the regional agreement on medical training and clinical research (AlF) between Stockholm County Council and Karolinska Institutet; Swedish Alzheimer Foundation; Swedish research Council; Karolinska Institutet PhD-student funding; King gustaf V and Queen Victoria’s Free Mason Foundation; the gun and Bertil Stohne’s Foundation, Foundation for Old Servants; Clinicians including Dr Vesna Jelic and Anne Börjesson-Hanson. For the Munich Institute of Human Genetics site H.P. was supported by the e-rare project geNOMIT (01gM1207), and the german Network for mitochondrial disorders (mitoNeT 01gM1113C). T.B.H. was supported by the NBIA disorders association. The Barcelona Sant Pau site was in part funded by a grant from the Spanish Ministry of economy and Competitiveness (grant Number PI12/01311) and CIBerNeD. The Pamplona Center for Applied Medical Research is indebted the UTe project from the Foundation for Applied Medical research (FIMA) and CIBerNeD. The Barcelona Neurological Tissue Bank site is indebted to the Neurological Tissue Bank of the IDIBAPS Biobanc for sample and data procurement. The Neurological Tissue Bank acknowledges all brain donors and relatives for generous brain donation for research and referring physicians. The Czech site was partially supported by grant IgA NT 12094-5 of grant Agency of the Czech Ministry of Health. The Verona site was in part supported by Fondazione Cariverona (grant Number 2009.1026 “Cognitive and behavioural disability in dementia and psychosis” to gMF). The Liege site was funded by the FNrS.
PY - 2014/9
Y1 - 2014/9
N2 - Mutations in the gene coding for Sequestosome 1 (SQSTM1) have been genetically associated with amyotrophic lateral sclerosis (ALS) and Paget disease of bone. In the present study, we analyzed the SQSTM1 coding sequence for mutations in an extended cohort of 1,808 patients with frontotemporal lobar degeneration (FTLD), ascertained within the European Early-Onset Dementia consortium. As control dataset, we sequenced 1,625 European control individuals and analyzed whole-exome sequence data of 2,274 German individuals (total n = 3,899). Association of rare SQSTM1 mutations was calculated in a meta-analysis of 4,332 FTLD and 10,240 control alleles. We identified 25 coding variants in FTLD patients of which 10 have not been described. Fifteen mutations were absent in the control individuals (carrier frequency <0.00026) whilst the others were rare in both patients and control individuals. When pooling all variants with a minor allele frequency <0.01, an overall frequency of 3.2 % was calculated in patients. Rare variant association analysis between patients and controls showed no difference over the whole protein, but suggested that rare mutations clustering in the UBA domain of SQSTM1 may influence disease susceptibility by doubling the risk for FTLD (RR = 2.18 [95 % CI 1.24-3.85]; corrected p value = 0.042). Detailed histopathology demonstrated that mutations in SQSTM1 associate with widespread neuronal and glial phospho-TDP-43 pathology. With this study, we provide further evidence for a putative role of rare mutations in SQSTM1 in the genetic etiology of FTLD and showed that, comparable to other FTLD/ALS genes, SQSTM1 mutations are associated with TDP-43 pathology.
AB - Mutations in the gene coding for Sequestosome 1 (SQSTM1) have been genetically associated with amyotrophic lateral sclerosis (ALS) and Paget disease of bone. In the present study, we analyzed the SQSTM1 coding sequence for mutations in an extended cohort of 1,808 patients with frontotemporal lobar degeneration (FTLD), ascertained within the European Early-Onset Dementia consortium. As control dataset, we sequenced 1,625 European control individuals and analyzed whole-exome sequence data of 2,274 German individuals (total n = 3,899). Association of rare SQSTM1 mutations was calculated in a meta-analysis of 4,332 FTLD and 10,240 control alleles. We identified 25 coding variants in FTLD patients of which 10 have not been described. Fifteen mutations were absent in the control individuals (carrier frequency <0.00026) whilst the others were rare in both patients and control individuals. When pooling all variants with a minor allele frequency <0.01, an overall frequency of 3.2 % was calculated in patients. Rare variant association analysis between patients and controls showed no difference over the whole protein, but suggested that rare mutations clustering in the UBA domain of SQSTM1 may influence disease susceptibility by doubling the risk for FTLD (RR = 2.18 [95 % CI 1.24-3.85]; corrected p value = 0.042). Detailed histopathology demonstrated that mutations in SQSTM1 associate with widespread neuronal and glial phospho-TDP-43 pathology. With this study, we provide further evidence for a putative role of rare mutations in SQSTM1 in the genetic etiology of FTLD and showed that, comparable to other FTLD/ALS genes, SQSTM1 mutations are associated with TDP-43 pathology.
KW - ALS
KW - FTLD
KW - P62
KW - Rare variants
KW - Sequestosome 1
KW - SQSTM1
UR - http://www.scopus.com/inward/record.url?scp=84906313820&partnerID=8YFLogxK
U2 - 10.1007/s00401-014-1298-7
DO - 10.1007/s00401-014-1298-7
M3 - Article
C2 - 24899140
AN - SCOPUS:84906313820
SN - 0001-6322
VL - 128
SP - 397
EP - 410
JO - Acta Neuropathologica
JF - Acta Neuropathologica
IS - 3
ER -